Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)
Clinical trial NCT03200587 · COMPLETED
Trial details
- NCT number
- NCT03200587
- Sponsor
- University of Utah
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-21
- Primary completion
- 2020-04-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.